Company attributes
Other attributes
Precision Biologics is a company that develops therapeutic drugs that are intended to aid early detection and treatment of cancer. Its monoclonal antibody drug candidates and diagnostics products detect and target the tumor while working without destroying healthy cells in the body, enabling physicians to treat cancer patients.
Precision Biologics is committed to improving the lives of cancer patients via its innovative therapeutic and diagnostic products. The company’s therapeutic program is focused on developing new drugs that can improve outcomes, extend survival, and improve patients' quality of life. The goal of the diagnostic program is to develop products that will enable earlier detection, and the potential for earlier intervention. Its current clinical trials are directed towards patients with late-stage solid tumors.
The company's mission is to boost and extend the lives of cancer patients by developing innovative diagnostics and therapeutics that selectively target tumors with precision.
